Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Min Hu,1,2 Fang Zeng,1,2 Zhendi Wang,3 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Hubei Province Clinical Research Center for Prec...

Full description

Bibliographic Details
Published in:	Pharmacogenomics and Personalized Medicine
Main Authors:	Cheng F, Li Q, Wang J, Hu M, Zeng F, Wang Z, Zhang Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-11-01
Subjects:	kidney transplantation tacrolimus metabolism pharmacogenetics immunosuppression
Online Access:	https://www.dovepress.com/genetic-polymorphisms-affecting-tacrolimus-metabolism-and-the-relation-peer-reviewed-fulltext-article-PGPM

Similar Items

Influence of Genetic Polymorphisms in CYP3A5, CYP3A4, and MDR1 on Tacrolimus Metabolism after kidney transplantation
by: Mirgul Bayanova, et al.
Published: (2024-04-01)

Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period
by: A. V. Shabunin, et al.
Published: (2023-04-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
by: Zhi-yu Zou, et al.
Published: (2023-12-01)

Generic tacrolimus in kidney transplant patients at Jordan University hospital
by: Ayman M Wahbeh, et al.
Published: (2024-01-01)

Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland
by: Marco Bonani, et al.
Published: (2021-02-01)

Herramientas para un ajuste de dosis de tacrolimus más personalizado en el seguimiento de los pacientes con transplante renal. Fenotipo metabolizador según polimorfismos genéticos del CYP3A vs. el cociente concentración-dosis
by: Anna Vidal-Alabró, et al.
Published: (2024-03-01)

Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01)

Personalizing immunosuppressive therapy: predictors of drug switches in Malaysian kidney transplant recipients
by: Chiau Ling Choong, et al.
Published: (2025-09-01)

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
by: Pere Fontova, et al.
Published: (2021-03-01)

Severe anorexia and weight loss induced by tacrolimus in kidney transplant recipients
by: Hong Pil Hwang, et al.
Published: (2021-06-01)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022-12-01)

Impact of CYP3A4 and CYP3A5 polymorphisms on tacrolimus dose requirements in Saudi kidney transplant patients
by: Marzog S. Al Nasser, et al.
Published: (2025-08-01)

Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study
by: Chang-Kwon Oh, et al.
Published: (2020-06-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Effect of tacrolimus formulation on neurocognition in older kidney transplant recipients: A randomized controlled trial
by: Hadia Lala Gul, et al.
Published: (2025-09-01)

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients
by: Alan D. Kaye, et al.
Published: (2024-12-01)

Association of P450 Oxidoreductase Gene Polymorphism with Tacrolimus Pharmacokinetics in Renal Transplant Recipients: A Systematic Review and Meta-Analysis
by: Da-Hoon Lee, et al.
Published: (2022-01-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Tacrolimus monitoring in hair samples of kidney transplant recipients
by: Alexander Born, et al.
Published: (2023-12-01)

Refining tacrolimus dosing through CYP3A5 pharmacogenetics in Taiwanese renal transplant recipients
by: Yen-Lin Chang, et al.
Published: (2025-12-01)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
by: Sebastian C. B. Bremer, et al.
Published: (2018-11-01)

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report
by: Louise Füessl, et al.
Published: (2024-06-01)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
by: Antony Brayan Campos-Salazar, et al.
Published: (2018-11-01)

Assessing drug-drug interactions of Tacrolimus with Fluconazole and/or Verapamil and developing the predictive model for Tacrolimus concentrations in kidney transplant recipients
by: Mingkwan Na Takuathung, et al.
Published: (2025-06-01)

Predicting Tacrolimus Concentrations in the Skin of Adult Kidney Transplant Recipients: A Feasibility Study
by: Felicity Sartain, et al.
Published: (2024-01-01)

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
by: Moritz Anft, et al.
Published: (2024-09-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Improved kidney function and one-year survival with transitioning from intravenous to enteral tacrolimus in lung transplant recipients
by: Carrie Burt, et al.
Published: (2024-06-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients
by: Jasper Kamp, et al.
Published: (2023-12-01)

Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study
by: Magali Giral, et al.
Published: (2024-04-01)

Comparing the effect of immediate versus delayed initiation of tacrolimus on delayed graft function in Kidney transplant recipients: A randomized open-label clinical trial
by: Maryam Ghadimi, et al.
Published: (2018-01-01)

Impact of genetic polymorphisms at the promoter area of IL-10 gene on tacrolimus level in Jordanian renal transplantation recipients
by: Khaleel Bara'ah, et al.
Published: (2022-01-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Impact of CYP3A5 1* and 3* single nucleotide variants on tacrolimus pharmacokinetics and graft rejection risk in pediatric kidney transplant patients
by: Lesly Yanira Xajil-Ramos, et al.
Published: (2025-05-01)

Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
by: Daniel A. Brazeau, et al.
Published: (2020-08-01)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)